[1] |
TORRES O, LINHARES MM, RAMOS E, et al. Liver Resection for Non-oriental Hepatolithiasis[J]. Arq Bras Cir Dig, 2019, 32(4): e1463. DOI: 10.1590/0102-672020190001e1463.
|
[2] |
CHA SW. Management of intrahepatic duct stone[J]. Korean J Gastroenterol, 2018, 71(5): 247-252. DOI: 10.4166/kjg.2018.71.5.247.
|
[3] |
SHANG D, ZHANG GX, ZHANG QK. Minimally invasive integrated traditional Chinese and Western medicine therapy for hepatolithiasis based on the SELECT concept[J]. J Clin Hepatol, 2020, 36(1): 31-35. DOI: 10.3969/j.issn.1001-5256.2020.01.005.
尚东, 张桂信, 张庆凯. 基于SELECT理念的中西医结合微创治疗肝胆管结石[J]. 临床肝胆病杂志, 2020, 36(1): 31-35. DOI: 10.3969/j.issn.1001-5256.2020.01.005.
|
[4] |
LI C, WEN T. Surgical management of hepatolithiasis: A minireview[J]. Intractable Rare Dis Res, 2017, 6(2): 102-105. DOI: 10.5582/irdr.2017.01027.
|
[5] |
CHEN W, YANG WQ, MENG XL, et al. Research progress in etiology of primary hepatolithiasis[J]. J Clin Hepatol, 2005, 21(3): 180-181. DOI: 10.3969/j.issn.1001-5256.2005.03.026.
陈伟, 杨文奇, 孟翔凌, 等. 原发性肝内胆管结石的病因学研究现状[J]. 临床肝胆病杂志, 2005, 21(3): 180-181. DOI: 10.3969/j.issn.1001-5256.2005.03.026.
|
[6] |
WEBER SN, BOPP C, KRAWCZYK M, et al. Genetics of gallstone disease revisited: Updated inventory of human lithogenic genes[J]. Curr Opin Gastroenterol, 2019, 35(2): 82-87. DOI: 10.1097/MOG.0000000000000511.
|
[7] |
RAN X, YIN B, MA B. Four major factors contributing to intrahepatic stones[J]. Gastroenterol Res Pract, 2017, 2017: 7213043. DOI: 10.1155/2017/7213043.
|
[8] |
AL SINANI S, AL-MULAABED S, AL NAAMANI K, et al. Cystic fibrosis liver disease: Know more[J]. Oman Med J, 2019, 34(6): 482-489. DOI: 10.5001/omj.2019.90.
|
[9] |
HUANG Q, DING W, WEI MX. Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population[J]. World J Gastroenterol, 2008, 14(12): 1925-1930. DOI: 10.3748/wjg.14.1925.
|
[10] |
PAGIN A, SERMET-GAUDELUS I, BURGEL PR. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders[J]. Arch Pediatr, 2020, 27(Suppl 1): eS25-eS29. DOI: 10.1016/S0929-693X(20)30047-6.
|
[11] |
European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones[J]. J Hepatol, 2016, 65(1): 146-181. DOI: 10.1016/j.jhep.2016.03.005.
|
[12] |
Group of Biliary Tract Surgery, Chinese Society of Surgery, Chinese Medical Association. The trend of the gallstone disease in China over the past decade[J]. Chin J Surg, 1995, 33(11): 652-658. DOI: 10.3760/j:issn:0529-5815.1995.11.007.
中华外科学会胆道外科学组. 我国胆石病十年来的变迁[J]. 中华外科杂志, 1995, 33(11): 652-658. DOI: 10.3760/j:issn:0529-5815.1995.11.007.
|
[13] |
ZSEMBERY A, JESSNER W, SITTER G, et al. Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells[J]. Hepatology, 2002, 35(1): 95-104. DOI: 10.1053/jhep.2002.30423.
|
[14] |
SAKIANI S, KLEINER DE, HELLER T, et al. Hepatic manifestations of cystic fibrosis[J]. Clin Liver Dis, 2019, 23(2): 263-277. DOI: 10.1016/j.cld.2018.12.008.
|
[15] |
EMINOGLU TF, POLAT E, GÖKÇE S, et al. Cystic fibrosis presenting with neonatal cholestasis simulating biliary atresia in a patient with a novel mutation[J]. Indian J Pediatr, 2013, 80(6): 502-504. DOI: 10.1007/s12098-012-0842-5.
|
[16] |
KO JM, KIM GH, KIM KM, et al. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis[J]. J Korean Med Sci, 2008, 23(5): 912-915. DOI: 10.3346/jkms.2008.23.5.912.
|
[17] |
KHAN HH, MEW NA, KAUFMAN SS, et al. Unusual cystic Fibrosis transmembrane conductance regulator mutations and liver disease: A case series and review of the literature[J]. Transplant Proc, 2019, 51(3): 790-793. DOI: 10.1016/j.transproceed.2018.11.007.
|
[18] |
WAHABI I, HADJ FREDJ S, NEFZI M, et al. Association of M470V polymorphism of CFTR gene with variability of clinical expression of asthma: Case-report study[J]. Allergol Immunopathol (Madr), 2019, 47(2): 159-165. DOI: 10.1016/j.aller.2018.06.007.
|
[19] |
JIN CX, FUJIKI K, SONG Y, et al. CFTR polymorphisms of healthy individuals in two Chinese cities-Changchun and Nanjing[J]. Nagoya J Med Sci, 2012, 74(3-4): 293-301. DOI: 10.1111/j.1582-4934.2011.01493.x.
|
[20] |
JIANG L, JIN J, WANG S, et al. CFTR gene mutations and polymorphism are associated with non-obstructive azoospermia: From case-control study[J]. Gene, 2017, 626: 282-289. DOI: 10.1016/j.gene.2017.04.044.
|
[21] |
SALINAS DB, AZEN C, YOUNG S, et al. Phenotypes of california CF newborn screen-positive children with CFTR 5T allele by TG repeat length[J]. Genet Test Mol Biomarkers, 2016, 20(9): 496-503. DOI: 10.1089/gtmb.2016.0102.
|
[22] |
JIANG M, LI Z, FU S, et al. IVS8-5T Allele of CFTR is the risk factor in chronic pancreatitis, especially in idiopathic chronic pancreatitis[J]. Am J Med Sci, 2020, 360(1): 55-63. DOI: 10.1016/j.amjms.2020.04.019.
|
[23] |
QIAO D, YI L, HUA L, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: A case-control study in Chinese Han population[J]. J Cyst Fibros, 2008, 7(3): 210-214. DOI: 10.1016/j.jcf.2007.07.011.
|